BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 7634759)

  • 1. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease.
    Lyon TD; Fell GS; Gaffney D; McGaw BA; Russell RI; Park RH; Beattie AD; Curry G; Crofton RJ; Gunn I
    Clin Sci (Lond); 1995 Jun; 88(6):727-32. PubMed ID: 7634759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
    Gollan JL; Stocks J; Dormandy TL; Sherlock S
    J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wilson's disease--a factor in the differential diagnosis in hepatopathies].
    Dastych M; Jezek P; Snelerová M
    Vnitr Lek; 1989 Jul; 35(7):695-700. PubMed ID: 2800377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
    Chowrimootoo GF; Ahmed HA; Seymour CA
    Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Wilson's disease: an experience over three decades.
    Gow PJ; Smallwood RA; Angus PW; Smith AL; Wall AJ; Sewell RB
    Gut; 2000 Mar; 46(3):415-9. PubMed ID: 10673307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Western blot analysis in patients with hypocaeruloplasminaemia.
    Chowrimootoo GF; Andoh J; Seymour CA
    QJM; 1997 Mar; 90(3):197-202. PubMed ID: 9093597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 10. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective biliary copper excretion in Wilson's disease: the role of caeruloplasmin.
    Davis W; Chowrimootoo GF; Seymour CA
    Eur J Clin Invest; 1996 Oct; 26(10):893-901. PubMed ID: 8911863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term body retention of radiocopper (67Cu) and the diagnosis of Wilson's disease.
    Willvonseder R; Goldstein NP; Tauxe WN
    Mayo Clin Proc; 1974 Jun; 49(6):387-93. PubMed ID: 4835809
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetics of radioactive copper in Wilson's disease].
    Willvonseder R; Goldstein NP; Tauxe WN
    Wien Z Inn Med; 1973; 54(5):226-33. PubMed ID: 4790777
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and management of Wilson's disease: results of a single center experience.
    Medici V; Trevisan CP; D'IncĂ  R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
    J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Occurrence of copper metabolism abnormalities in the families of four individuals with newly diagnosed Wilson's disease].
    Dastych M
    Vnitr Lek; 1997 Feb; 43(2):87-90. PubMed ID: 9245074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Wilson's disease presenting as fulminant hepatic failure.
    McCullough AJ; Fleming CR; Thistle JL; Baldus WP; Ludwig J; McCall JT; Dickson ER
    Gastroenterology; 1983 Jan; 84(1):161-7. PubMed ID: 6847842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
    Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
    J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.